Compression Behavior Evaluation of Directly Compressible Excipients

Abstract:

This work proposes to study the compression behavior of the directly compressible excipients microcrystalline cellulose (MCC). Many factors play a significant role in the compression behavior, such as the particle size and particle size distribute, flowability, particle density, porosity and so on, thus making it necessary to understand the dominant contribution of each factor. We studied the compression behavior of different types of MCC from three aspects: the physicmechanical properties, compression process and tablet mechanic characteristics of the excipients. As expected from the elastic recovery measurements, the MCC gave coherent tablets that could be handled under the chosen experimental conditions.

• Periodical: Advanced Materials Research (Volumes 482-484)
• Pages: 1672-1676
• DOI: https://doi.org/10.4028/www.scientific.net/AMR.482-484.1672
• Online since: February 2012
• Authors: Yan Du, Li Jie Zhao, Yi Feng, De Sheng Xu
• Keywords: Compaction Property, Compression Behavior, Mechanics Characteristics, Microcrystalline Cellulose (MCC), Yield Pressure

References

[1] Jivraj I, Martini L, Thomson C. An overview of the different excipients useful for the direct compression of tablets. Pharmaceutical science & technology today. 2000;3(2):58-63.

DOI: 10.1016/s1461-5347(99)00237-0

[2] Antikainen O. Determining the compression behaviour of pharmaceutical powders from the force–distance compression profile. International Journal of Pharmaceutics. 2003;252(1-2):253-261.

DOI: 10.1016/s0378-5173(02)00665-8

[3] Heckel RW. An analysis of powder compaction phenomena. Trans Metal Soc Aime. 1961;221:1001.

[4] Heckel RW. Density pressure relationship in powder compaction. Trans Metallurgical Soc of AIME. 1961;221:671.

[5] Kavakita K, Lüdde KH. Some Considerations on Powder Compression Equations. Powder Technology. 1971;4:61-68. 6. Michrafy a, Michrafy M, Kadiri MS, Dodds J.

DOI: 10.1016/0032-5910(71)80001-3

[6] Predictions of tensile strength of binary tablets using linear and power law mixing rules. International journal of pharmaceutics. 2007;333(1-2):118-26.

DOI: 10.1016/j.ijpharm.2006.10.008

[7] Cantor SL, Hoag SW, Augsburger LL. 7.Evaluation of the mechanical properties of extrusion-spheronized beads and multiparticulate systems. Drug Development and Industrial Pharmacy. 2009;35(6):683-693.

DOI: 10.1080/03639040802526797

[8] Kachrimanis K, Malamataris S. "Apparent" Young's elastic modulus and radial recovery for some tableted pharmaceutical excipients. European Journal of Pharmaceutical Sciences. 2004;21(2-3):197-207.

DOI: 10.1016/j.ejps.2003.10.014

[9] Autamashih M, Ab I, Ts A, Ma I. Heckel and Kawakita analyses of granules of the crude leaves extract of vernonia galamensis prepared using polyvinylpyrrolidone as binder. International Journal of Pharmaceutics. 2011;3(4).

[10] Hausner H. Friction conditions in a mass of metal powder. Int J Powder Metall. 1967;3:7–13. 1.

[11] Carr RL. Evaluating flow properties of solids. Chem Eng. 1965;72(2):163–168.

[12] Malaj L, Censi R, Gashi Z, Martino P Di. Compression behaviour of anhydrous and hydrate forms of sodium naproxen. International journal of pharmaceutics. 2010;390(2):142-9.

DOI: 10.1016/j.ijpharm.2010.01.036

[13] Patel S, Kaushal AM, Bansal AK. Mechanistic investigation on pressure dependency of Heckel parameter. International Journal of Pharmaceutics. 2010;389(1-2):66-73.

DOI: 10.1016/j.ijpharm.2010.01.020

[14] The United States Pharmacopeial Convention, Inc. U.S. Pharmacopeia; USP 29-NF 24,372:1174-1175.

[15] Patel S, Kaushal AM, Bansal AK. Compaction behavior of roller compacted ibuprofen. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V. 2008;69(2):743-9.

DOI: 10.1016/j.ejpb.2008.01.005

[16] Wu C-Y, Best SM, Bentham AC, Hancock BC, Bonfield W. A simple predictive model for the tensile strength of binary tablets. European journal of pharmaceutical sciences official journal of the European Federation for Pharmaceutical Sciences. 2005;25(2-3):331-336.

DOI: 10.1016/j.ejps.2005.03.004